West Pharmaceutical Services Inc (WST)

Operating return on assets (Operating ROA)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Operating income (ttm) US$ in thousands 676,000 644,800 653,700 699,600 734,000 788,300 783,500 766,400 752,300 684,400 602,200 494,500 406,900 368,900 337,000 313,900 296,600 284,300 277,800 257,600
Total assets US$ in thousands 3,829,500 3,754,700 3,669,600 3,723,600 3,616,800 3,316,800 3,361,700 3,294,700 3,313,800 3,142,600 2,933,500 2,739,700 2,793,800 2,582,800 2,392,300 2,246,500 2,341,400 2,174,000 2,123,200 2,036,200
Operating ROA 17.65% 17.17% 17.81% 18.79% 20.29% 23.77% 23.31% 23.26% 22.70% 21.78% 20.53% 18.05% 14.56% 14.28% 14.09% 13.97% 12.67% 13.08% 13.08% 12.65%

December 31, 2023 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $676,000K ÷ $3,829,500K
= 17.65%

West Pharmaceutical Services, Inc.'s operating return on assets (operating ROA) has shown a declining trend over the past few quarters. The operating ROA decreased from 23.79% in Q3 2022 to 18.47% in Q4 2023, indicating a decline in the company's ability to generate profits from its assets through operations. This downward trend suggests that the company may be experiencing challenges in efficiently utilizing its assets to generate operating income. Further analysis and investigation into the factors driving this decline in operating ROA would be beneficial to determine the root causes and develop strategies for improvement.


Peer comparison

Dec 31, 2023

Company name
Symbol
Operating ROA
West Pharmaceutical Services Inc
WST
17.65%
Carlisle Companies Incorporated
CSL
14.85%